Jeffrey S. Hatfield Insider Trading $LRMR Larimar Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey S. Hatfield.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey S. Hatfield. Jeffrey S. Hatfield is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Chief Executive Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Director in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV) and Director in aTYR PHARMA INC ($LIFE) and Chief Executive Officer in ZAFGEN, INC. ($ZFGN) and Director in MIRAGEN THERAPEUTICS, INC. ($MGEN) and Director in Vir Biotechnology, Inc. ($VIR).
Jeffrey S. Hatfield in Larimar Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey S. Hatfield: Chief Executive Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 24 2019
$LRMR Market Capitalization: $109.05M
$LRMR Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jeffrey S. Hatfield in Larimar Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMBI, LIFE, NVIV, LRMR, VIR, MGEN, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2019 | ZFGN | ZAFGEN, INC. | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | A | 4.63 | 525,000 | 2,430,750 | 525,000 | |
| Feb 23 2018 | ZFGN | ZAFGEN, INC. | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | A | 7.77 | 275,000 | 2,136,750 | 275,000 | |
| Dec 29 2017 | ZFGN | ZAFGEN, INC. | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | A | 3.40 | 1,100,000 | 3,740,000 | 1,100,000 | |
| Oct 11 2017 | ZFGN | ZAFGEN, INC. | Hatfield Jeffrey S. | Chief Executive Off ... | Option Exercise | A | 3.40 | 550,000 | 1,870,000 | 550,000 |
Page: 1